Circulating soluble tumor necrosis factor related apoptosis inducing-ligand (TRAIL) is decreased in type-2 newly diagnosed, non-drug using diabetic patients

Bisgin, A.; Yalcin, A.; Gorczynski, R.

doi:10.1016/j.diabres.2012.02.028

Circulating soluble tumor necrosis factor related apoptosis inducing-ligand (TRAIL) is decreased in type-2 newly diagnosed, non-drug using diabetic patients

Bisgin A., Yalcin A. D., Gorczynski R. M.

DIABETES RESEARCH AND CLINICAL PRACTICE, vol.96, no.3, 2012 (SCI-Expanded, Scopus)

Publication Type: Article / Article
Volume: 96 Issue: 3
Publication Date: 2012
Doi Number: 10.1016/j.diabres.2012.02.028
Journal Name: DIABETES RESEARCH AND CLINICAL PRACTICE
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Keywords: Soluble TRAIL, Type-2 diabetes mellitus, Non-drug using diabetic patients, RHEUMATOID-ARTHRITIS, DISEASE, CELLS, EXPRESSION, CORRELATE, SEVERITY, CANCER
Akdeniz University Affiliated: Yes

Abstract

We examined the association between serum sTRAIL measured by ELISA and HbA1C levels, pre/post-prandial blood glucose levels and body mass index in 22 newly diagnosed type-2 diabetic patients.